Chataway, Jeremy
De Angelis, Floriana
Connick, Peter
Parker, Richard A
Plantone, Domenico
Doshi, Anisha
John, Nevin
Stutters, Jonathan
MacManus, David
Prados Carrasco, Ferran
Barkhof, Frederik
Ourselin, Sebastien
Braisher, Marie
Ross, Moira
Cranswick, Gina
Pavitt, Sue H
Giovannoni, Gavin
Gandini Wheeler-Kingshott, Claudia Angela
Hawkins, Clive
Sharrack, Basil
Bastow, Roger
Weir, Christopher J
Stallard, Nigel
Chandran, Siddharthan
Chataway, Jeremy
Gandini Wheeler-Kingshott, Claudia A.M.
De Angelis, Floriana
Plantone, Domenico
Doshi, Anisha
John, Nevin
Williams, Thomas
Braisher, Marie
Beyene, Tiggy
Bassan, Vanessa
Zapata, Alvin
Chandran, Siddharthan
Connick, Peter
Lyle, Dawn
Cameron, James
Mollison, Daisy
Colville, Shuna
Dhillon, Baljean
Weir, Christopher J.
Parker, Richard A.
Ross, Moira
Cranswick, Gina
Giovannoni, Gavin
Gnanapavan, Sharmilee
Nicholas, Richard
Rashid, Waqar
Aram, Julia
Ford, Helen
Overell, James
Young, Carolyn
Arndt, Heinke
Duddy, Martin
Guadagno, Joe
Evangelou, Nikolaos
Craner, Matthew
Palace, Jacqueline
Hobart, Jeremy
Sharrack, Basil
Paling, David
Hawkins, Clive
Kalra, Seema
McLean, Brendan
Stallard, Nigel
Bastow, Roger
Funding for this research was provided by:
National Multiple Sclerosis Society
Medical Research Council
National Institute for Health and Care Research
University College London (11/30/11)
University of Edinburgh
This article is maintained by: Elsevier
Article Title: Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial
Journal Title: The Lancet Neurology
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S1474-4422(19)30485-5
CrossRef DOI link to the associated document: https://doi.org/10.1016/S1474-4422(19)30487-9
Content Type: article
Copyright: © 2020 The Author(s). Published by Elsevier Ltd.